2nd Quarter - Amendment
PODESTA.COM for AIM IMMUNOTECH INC.
Firm
Client
Income
$60,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 19, 2023 | $60,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Oct 20, 2023 | $60,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to cancer treatment and Cancer Moonshot Initiative Issues related to COVID therapies and NIH RECOVER Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH DEMAREE | — |
| HELEN HAGERTY New | — |
| ANTHONY PODESTA | — |
Budget/Appropriations BUD
Issues related to funding for clinical trials.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH DEMAREE New | — |
| HELEN HAGERTY New | — |
| ANTHONY PODESTA | — |
Financial Institutions/Investments/Securities FIN
Issues related to SEC compliance and enforcement
| Lobbyist | Covered position, as disclosed |
|---|---|
| HELEN HAGERTY | — |
| ANTHONY PODESTA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.